A
ARGX
Argenx Se
799.65
-0.85-0.11%After Hours: 799.65 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE808.27/800.50
TODAY RANGE793.95-809.72
VOL312.25K
MARKET CAP49.63B
52 WEEK RANGE510.06-934.62
AVG VOL (3M)366.35K
% TURNOVER0.50%
TURNOVER--
P/E (TTM)40.87
% RANGE1.97%
EPS(TTM)19.57
P/E(FORWARD)31.17
P/B6.76
BVPS118.34
DIVIDEND--
P/S11.92
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP49.48B
SHARES OUTSTANDING62.06M
NEXT EARNINGS02/29-03/04
FREE FLOAT61.88M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
RBC Capital Reaffirms Their Buy Rating on Argenx Se (ARGX)
Benzinga·4d ago
Why Is Viridian Therapeutics Stock Sinking Monday?
Seeking Alpha·4d ago
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
Dow Jones·04/02 16:32
argenx Is Maintained at Outperform by Oppenheimer
Dow Jones·04/02 16:32
argenx Price Target Cut to $1014.00/Share From $1060.00 by Oppenheimer
Benzinga·04/02 16:22
Oppenheimer Maintains Outperform on argenx, Lowers Price Target to $1014
TipRanks·04/02 11:52
Argenx price target lowered to $1,014 from $1,060 at Oppenheimer
TipRanks·04/02 07:56
arGEN X (0QW0) Gets a Hold from UBS
TipRanks·04/01 12:25
arGEN X (0QW0) Receives a Buy from Goldman Sachs
TipRanks·04/01 10:56
Argenx Se (ARGX) Gets a Buy from Wells Fargo
TipRanks·04/01 08:31
Argenx added to European Conviction List at Goldman Sachs
TipRanks·04/01 08:16
UBS Keeps Their Hold Rating on Argenx Se (ARGX)
Barron‘s·03/31 20:36
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs